OOIR: Observatory of International Research

Papers

(The H4-Index of BMC Cancer is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up	174
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma	154
Clinical benefits of enhanced 3D-NEVERview sequence in MRI simulation for nasopharyngeal carcinoma patients received radiotherapy	141
The mortality rate of people with cancer judged to have a limited life expectancy by physicians performing work disability assessments in the Netherlands: a retrospective cohort study	76
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis	75
Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting	74
Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis	74
Analysis of characteristics of peripheral blood lymphocytes in endometrial carcinoma: a single-center study based on five-year clinical data	70
Beta-Blockers and mortality in patients with malignancy and cardiovascular disease: an analysis of the MIMIC-IV database	69
Ten-year follow-up of atypical small acinar hyperplasia cases diagnosed by initial prostate biopsy	67
Targeting INF2 with DiosMetin 7-O-β-D-Glucuronide: a new stratagem for colorectal cancer therapy	64
Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, random	63
Development and internal validation of a lymphoma-specific nomogram for predicting venous thromboembolism: a retrospective cohort of 790 patients	62
Dynamic CEA kinetics as a prognostic biomarker for HER2-negative advanced gastric cancer treated with chemoimmunotherapy	61
Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel Cell Carcinoma: a systematic review and Meta-analysis	60
Association between preoperative anxiety states and postoperative complications in patients with esophageal cancer and COPD: a retrospective cohort study	60
Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients	60
“It's very important that you measure throughout that journey…”: patient perspectives towards quality-of-life data collection following haematopoietic cell transplant	59
Clinicopathologic and prognosis of 30 patients with FH-deficient renal cell carcinoma: a single-center retrospective study	59
Combined technology-enhanced home exercise and acupressure (TEHEplus) program on symptoms among cancer patients receiving immunotherapy: a feasibility study	58
α-L-fucosidase isoenzymes (FUCA1/FUCA2) as prognostic markers in gliomas: a comprehensive study	57
Age-related differences in adjuvant chemotherapy use and outcomes in stage II colon cancer: a retrospective cohort study	55
Assessing the performance of QLQ-C30 in predicting all-cause mortality in community cancer patients	52
Safety and feasibility of liver resection including major hepatectomy for geriatric patients with hepatocellular carcinoma: a retrospective observational study	52
Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer	52

Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study	51
Effectiveness of axicabtagene ciloleucel versus conventional treatments as first-line therapy for high-risk large B-cell lymphoma: an external comparator study	51
MTF1 genetic variants are associated with lung cancer risk in the Chinese Han population	51
Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation	51
PReCedeNT trial: Phase III randomized-controlled trial of Lutetium − 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gast	50
Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients	50
Risk factors and predictive model of lymph node metastasis in clinical stage IA peripheral non-small cell lung cancer: a retrospective study	49
High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis	49
Factors affecting post-traumatic growth in hematopoietic stem cell transplantation patients in South Korea: a descriptive survey study	49
Innovative inhalable dry powder: nanoparticles loaded with Crizotinib for targeted lung cancer therapy	49
Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy	48
Adipogenesis biomarkers as the independent predictive factors for breast cancer recurrence: a systematic review and meta-analysis	48
Impact of lenalidomide consolidation on health-related quality of life in chronic lymphocytic leukemia: ancillary study of the phase III CLL6-RESIDUUM trial	48
Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor	48
Tumor-Infiltrating lymphocyte dynamics as biomarkers of neoadjuvant treatment response in luminal breast cancer	47
Short-term impact of delayed surgical treatment on the prognosis of patients with T1bN1-stage PTC: a retrospective cohort study	47
Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis	47
High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinoma	47
Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a mu	46
Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p/PTEN signaling	46
L-arginine dependence of breast cancer – molecular subtypes matter.	46